|
STOCKHOLM, Feb. 22, 2019 /PRNewswire/ -- Summary of Q4 Read more ›› |
|
By: PR Newswire Association LLC. - 22 Feb 2019
|
|
Related companies:
Oncopeptides AB |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 21 Feb 2019
|
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 21 Feb 2019
|
|
Related companies:
Össur Nordic AB |
Össur Germany GmbH |
Össur Americas, Inc. |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 21 Feb 2019
|
|
Related companies:
AroCell AB |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 21 Feb 2019
|
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 21 Feb 2019
|
|
Related companies:
Xbrane Biopharma AB |
|
|
STOCKHOLM, Feb. 21, 2019 /PRNewswire/ -- Save the date for Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) Capital Markets... Read more ›› |
|
By: PR Newswire Association LLC. - 21 Feb 2019
|
|
Related companies:
Swedish Orphan Biovitrum AB (Sobi™) |
Swedish Orphan Biovitrium AB |
|
|
STOCKHOLM, Feb. 21, 2019 /PRNewswire/ -- Read more ›› |
|
By: PR Newswire Association LLC. - 21 Feb 2019
|
|
|
LUND, Sweden, Feb. 21, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the company has entered into an exclusive agreement to license and supply two of its first generation of succinate/malonate prodrugs as research tool compounds... Read more ›› |
|
By: PR Newswire Association LLC. - 21 Feb 2019
|
|
Related companies:
NeuroVive Pharmaceutical AB |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 21 Feb 2019
|
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 20 Feb 2019
|
|
Related companies:
Xbrane Biopharma AB |
|
|
STOCKHOLM, Feb. 20, 2019 /PRNewswire/ -- Read more ›› |
|
By: PR Newswire Association LLC. - 20 Feb 2019
|
|
Related companies:
SCIBASE HOLDING AB |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 20 Feb 2019
|
|
Related companies:
Acarix AB |
|
|
STOCKHOLM, Feb. 20, 2019 /PRNewswire/ -- "We summarize 2018 and conclude: RaySearch stands strong. Order intake rose by 19 percent and RayCare has been introduced into clinical use" Read more ›› |
|
By: PR Newswire Association LLC. - 20 Feb 2019
|
|
Related companies:
RaySearch Laboratories AB |
|
|
STOCKHOLM, Feb. 20, 2019 /PRNewswire/ - Period October - December 2018 Read more ›› |
|
By: PR Newswire Association LLC. - 20 Feb 2019
|
|
Related companies:
INDEX PHARMACEUTICALS HOLDING AB |
|
|
STOCKHOLM, Feb. 20, 2019 /PRNewswire/ -- Read more ›› |
|
By: PR Newswire Association LLC. - 20 Feb 2019
|
|
Related companies:
SCIBASE HOLDING AB |
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 19 Feb 2019
|
|
|
| Read more ›› |
|
By: Nasdaq / GlobenewsWire - 19 Feb 2019
|
|
|
STOCKHOLM, Feb. 19, 2019 /PRNewswire/ -- Oncoinvent is pleased to announce that it has received a manufacturing authorization (GMP certificate) for production of Radspherin® clinical trial material from the Norwegian Medicine Agency. Read more ›› |
|
By: PR Newswire Association LLC. - 19 Feb 2019
|
|
|
LINKÖPING, Sweden, Feb. 19, 2019 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B)... Read more ›› |
|
By: PR Newswire Association LLC. - 19 Feb 2019
|
|
Related companies:
Sectra AB |
|
|
|
|
|
Biotechgate Global Database ›
